Pricing
Login
Home
Charts
Search
Watchlist
Products

Remus Pharmaceuticals Ltd

REMUS
₹817.60+2.84%20 Nov 2026
Reports
Pharma Others

Remus Pharmaceuticals Ltd

REMUS
₹817.60
+2.84%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹963Cr
Close
Close Price
₹817.60
Industry
Industry
Pharma Others
PE
Price To Earnings
19.57
PS
Price To Sales
0.90
Revenue
Revenue
₹1,068Cr
Rev Gr TTM
Revenue Growth TTM
42.73%
PAT Gr TTM
PAT Growth TTM
16.79%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
29185273348400453614
Growth YoY
Revenue Growth YoY%
839.088.146.830.453.5
Expenses
ExpensesCr
20165252323373424584
Operating Profit
Operating ProfitCr
9202125273030
OPM
OPM%
31.910.87.57.06.76.64.9
Other Income
Other IncomeCr
2333344
Interest Expense
Interest ExpenseCr
0011111
Depreciation
DepreciationCr
0101112
PBT
PBTCr
11232327293333
Tax
TaxCr
3445777
PAT
PATCr
8191921222525
Growth YoY
PAT Growth YoY%
140.68.214.919.514.2
NPM
NPM%
26.910.36.95.95.45.44.0
EPS
EPS₹
1.34.011.917.518.320.920.9
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
29185273348400453614
Growth YoY
Revenue Growth YoY%
839.088.146.830.453.5
Expenses
ExpensesCr
20165252323373424584
Operating Profit
Operating ProfitCr
9202125273030
OPM
OPM%
31.910.87.57.06.76.64.9
Other Income
Other IncomeCr
2333344
Interest Expense
Interest ExpenseCr
0011111
Depreciation
DepreciationCr
0101112
PBT
PBTCr
11232327293333
Tax
TaxCr
3445777
PAT
PATCr
8191921222525
Growth YoY
PAT Growth YoY%
140.68.214.919.514.2
NPM
NPM%
26.910.36.95.95.45.44.0
EPS
EPS₹
1.34.011.917.518.320.920.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2136208541,068
Growth
Revenue Growth%
191.937.642.7
Expenses
ExpensesCr
1855757971,008
Operating Profit
Operating ProfitCr
28465760
OPM
OPM%
13.17.46.65.6
Other Income
Other IncomeCr
5578
Interest Expense
Interest ExpenseCr
0112
Depreciation
DepreciationCr
1233
PBT
PBTCr
32475966
Tax
TaxCr
691314
PAT
PATCr
26384649
Growth
PAT Growth%
47.920.216.8
NPM
NPM%
12.26.25.44.6
EPS
EPS₹
5.432.639.241.8
Financial YearMar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2136208541,068
Growth
Revenue Growth%
191.937.642.7
Expenses
ExpensesCr
1855757971,008
Operating Profit
Operating ProfitCr
28465760
OPM
OPM%
13.17.46.65.6
Other Income
Other IncomeCr
5578
Interest Expense
Interest ExpenseCr
0112
Depreciation
DepreciationCr
1233
PBT
PBTCr
32475966
Tax
TaxCr
691314
PAT
PATCr
26384649
Growth
PAT Growth%
47.920.216.8
NPM
NPM%
12.26.25.44.6
EPS
EPS₹
5.432.639.241.8
Sales CAGR
1 Year38%
3 Years-
5 Years-
TTM-
EBITDA CAGR
1 Year24%
3 Years-
5 Years-
TTM-
PAT CAGR
1 Year20%
3 Years-
5 Years-
TTM-
Avg. ROCE
1 Year16%
3 Years22%
5 Years-
TTM12%
CFO / EBITDA
1 Year32%
3 Years22%
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161212
Reserves
ReservesCr
85250339524
Current Liabilities
Current LiabilitiesCr
149122149
Non Current Liabilities
Non Current LiabilitiesCr
32942
Total Liabilities
Total LiabilitiesCr
257433579788
Current Assets
Current AssetsCr
210221295
Non Current Assets
Non Current AssetsCr
48211284
Total Assets
Total AssetsCr
257433579788
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161212
Reserves
ReservesCr
85250339524
Current Liabilities
Current LiabilitiesCr
149122149
Non Current Liabilities
Non Current LiabilitiesCr
32942
Total Liabilities
Total LiabilitiesCr
257433579788
Current Assets
Current AssetsCr
210221295
Non Current Assets
Non Current AssetsCr
48211284
Total Assets
Total AssetsCr
257433579788

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4718
Investing Cash Flow
Investing Cash FlowCr
-9-11-15
Financing Cash Flow
Financing Cash FlowCr
2461
Net Cash Flow
Net Cash FlowCr
1935
Free Cash Flow
Free Cash FlowCr
334
CFO To PAT
CFO To PAT%
13.918.239.3
CFO To EBITDA
CFO To EBITDA%
12.915.332.0
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4718
Investing Cash Flow
Investing Cash FlowCr
-9-11-15
Financing Cash Flow
Financing Cash FlowCr
2461
Net Cash Flow
Net Cash FlowCr
1935
Free Cash Flow
Free Cash FlowCr
334
CFO To PAT
CFO To PAT%
13.918.239.3
CFO To EBITDA
CFO To EBITDA%
12.915.332.0

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,0161,319740963
Price To Earnings
Price To Earnings
49.445.420.019.6
Price To Sales
Price To Sales
4.82.10.90.9
Price To Book
Price To Book
6.45.22.12.7
EV To EBITDA
EV To EBITDA
36.029.213.316.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.412.711.811.8
OPM
OPM%
13.17.46.65.6
NPM
NPM%
12.26.25.44.6
ROCE
ROCE%
32.817.516.012.1
ROE
ROE%
29.915.013.29.2
ROA
ROA%
10.18.98.06.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,0161,319740963
Price To Earnings
Price To Earnings
49.445.420.019.6
Price To Sales
Price To Sales
4.82.10.90.9
Price To Book
Price To Book
6.45.22.12.7
EV To EBITDA
EV To EBITDA
36.029.213.316.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.412.711.811.8
OPM
OPM%
13.17.46.65.6
NPM
NPM%
12.26.25.44.6
ROCE
ROCE%
32.817.516.012.1
ROE
ROE%
29.915.013.29.2
ROA
ROA%
10.18.98.06.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr3,7243,3022,0592,0581,569963394
Close PriceClose₹84.16468.9521.90335.951,110.15817.60893.20
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE82.519.7421.68111.615.6719.5711.99
Price To SalesPS32.911.393.972.851.710.902.30
RevenueRevenueCr1132,3695187219181,068171
Revenue Growth TTMRev Gr TTM%222.2%6.4%0.6%19.4%11.3%42.7%7.8%
PAT Growth TTMPAT Gr TTM%270.5%283.1%51.6%323.7%317.3%16.8%-0.4%
Market CapitalizationMkt CapCr3,7243,3022,0592,0581,569963394
Close PriceClose₹84.16468.9521.90335.951,110.15817.60893.20
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE82.519.7421.68111.615.6719.5711.99
Price To SalesPS32.911.393.972.851.710.902.30
RevenueRevenueCr1132,3695187219181,068171
Revenue Growth TTMRev Gr TTM%222.2%6.4%0.6%19.4%11.3%42.7%7.8%
PAT Growth TTMPAT Gr TTM%270.5%283.1%51.6%323.7%317.3%16.8%-0.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
Quarterly Reports
FY2026
Jun 25
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 25
Result
PPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Load More
Interviews